Product Introduction :

The GI-MAP is a comprehensive stool analysis that looks at DNA and uses quantitative Polymerase Chain Reaction (qPCR) technology to evaluate gut pathogens, bacterial infections, viruses, and parasites.

Unlike other comprehensive stool testing offered the market, the GI-MAP identifies the quantitative value corresponding to each biomarker. This quantitative analysis allows practitioners to see how high or low a value is and whether it needs to be treated. The positive and negative values other stool testing analyses provide lack this specificity.

The GI-MAP uses qPCR technology that looks at the DNA of the pathogens within the gut (rather than the DNA of the patient). This gene-sequencing technology offers unmatched insight into precisely what is occurring in a patient’s gastrointestinal (GI) tract. Treatment progress can be monitored on retests by viewing whether the quantitative value of a biomarker has responded to treatment.

The GI-MAP also reports on antibiotic resistance and virulence factors, helping to take the guesswork out of treatment. The gut is highly complex; and, the GI-MAP optimizes the practitioner’s ability to practice personalized, precision medicine by reporting on the specific DNA findings within a patient’s microbiome.